ZERIA PHARMACEUTICAL CO.,LTD., First Half Ordinary Profit Increases by 45%, July-September Ordinary Profit Increases by 16%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Wed Nov 6, 2024 4:00 pm JST Earnings

4559 ZERIA PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Earnings Report

ZERIA PHARMACEUTICAL CO.,LTD. <4559> [TSE-P] announced its financial results after the market closed on November 6th (16:00). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2025 (April to September) expanded to 7.94 billion yen, an increase of 44.7% compared to the same period last year. The progress rate against the 11 billion yen full-year plan was 72.3%, also surpassing the five-year average of 53.6%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to grow by 1.1% from the same period last year, reaching 3.05 billion yen.

In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit grew by 16.4% from the same period last year, reaching 2.49 billion yen. However, the operating profit margin decreased from 12.8% in the same period last year to 12.0%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Sep, 2022	33,712	5,894	5,182	3,998	90.4	68.4	Nov 2, 2022	J-GAAP
Apr - Sep, 2023	36,678	5,327	5,495	5,396	122.4	64.5	Nov 1, 2023	J-GAAP
Apr - Sep, 2024	42,422	6,459	7,949	6,061	137.5	72.3	Nov 6, 2024	J-GAAP
YoY	+15.7%	+21.3%	+44.7%	+12.3%	+12.3%

First Half Results vs. Previous Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Apr - Sep, 2024 Guidance	42,420	6,450	7,940	6,060	137.5	23	Nov 5, 2024	J-GAAP
Apr - Sep, 2024 Results	42,422	6,459	7,949	6,061	137.5	23	Nov 6, 2024	J-GAAP
Revision Rate	+0.0%	+0.1%	+0.1%	+0.0%	+0.0%

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	39,047	4,294	3,018	2,335	53.0	22	May 9, 2024	J-GAAP
Oct - Mar, 2024 Guidance	43,578	4,541	3,051	2,439	55.3	23	Nov 6, 2024	J-GAAP
YoY	+11.6%	+5.8%	+1.1%	+4.5%	+4.5%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	68,383	9,014	7,579	6,195	140.3	40	May 11, 2023	J-GAAP
Mar, 2024	75,725	9,621	8,513	7,731	175.4	44	May 9, 2024	J-GAAP
Mar, 2025 Guidance	86,000	11,000	11,000	8,500	192.8	46	Nov 5, 2024	J-GAAP
YoY	+13.6%	+14.3%	+29.2%	+9.9%	+9.9%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jul - Sep, 2023	18,374	2,357	2,140	2,481	56.3	12.8	Nov 1, 2023	J-GAAP
Oct - Dec, 2023	21,241	4,163	3,949	3,027	68.7	19.6	Feb 1, 2024	J-GAAP
Jan - Mar, 2024	17,806	131	-931	-692	-15.7	0.7	May 9, 2024	J-GAAP
Apr - Jun, 2024	21,455	3,939	5,459	4,212	95.6	18.4	Aug 1, 2024	J-GAAP
Jul - Sep, 2024	20,967	2,520	2,490	1,849	42.0	12.0	Nov 6, 2024	J-GAAP
YoY	+14.1%	+6.9%	+16.4%	-25.5%	-25.5%